Application 011719

Type
NDA
Sponsor
HOSPIRA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 20MG BASE/VIALNoNo
003METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 50MG BASE/VIALNoNo
004METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 2.5MG BASE/MLNoNo
005METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 25MG BASE/MLNoNo
006METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 100MG BASE/VIALNoNo
007METHOTREXATE LPFMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 25MG BASE/MLNoNo
009METHOTREXATE SODIUM PRESERVATIVE FREEMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/VIALNoNo
010METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 50MG BASE/2ML (EQ 25MG BASE/ML)YesYes
011METHOTREXATE PRESERVATIVE FREEMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)NoNo
012METHOTREXATE SODIUM PRESERVATIVE FREEMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/40ML (EQ 25MG BASE/ML)YesYes
013METHOTREXATE PRESERVATIVE FREEMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
014METHOTREXATE PRESERVATIVE FREEMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 20MG BASE/2ML (EQ 10MG BASE/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
61703-124MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-350MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMETHOTREXATEHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMETHOTREXATEHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent
61703-408MethotrexateMethotrexateHospira, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82358SUPPL 2025-05-30
82341SUPPL 2025-05-29
79105SUPPL 2024-07-16
79104SUPPL 2024-07-16
76613SUPPL 2024-07-16
76607SUPPL 2023-11-17
70917SUPPL2022-05-03
70913SUPPL2022-05-03
66922SUPPL2021-03-30
66921SUPPL2021-03-30
54048SUPPL2018-05-08
54036SUPPL2018-05-07
53060SUPPL2018-03-20
53041SUPPL2018-03-16
10775SUPPL2015-11-25
11956SUPPL2015-11-23
33054SUPPL2011-11-04
11955SUPPL2011-11-03
11954SUPPL2005-04-19
11953SUPPL2004-12-30
10774SUPPL2004-02-03
11952SUPPL2004-02-02
11951SUPPL2003-08-06
283SUPPL2003-01-03
11950SUPPL2002-02-20
282SUPPL2002-02-20